BioAmber Inc. (BioAmber), formerly DNP Green Technology, Inc., is an industrial biotechnology company, which produces sustainable chemicals. The Company's technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, food additives and personal care products. Its geographical segments include Europe and North America. Its product pipeline includes the derivatives of bio-succinic acid, such as 1,4 Butanediol (1,4 BDO) and tetrahydrofuran (THF), and succinic acid-based polyesters, and C6 building block chemicals, such as adipic acid, caprolactam and hexamethylenediamine (HMDA). Its products are used in various applications, including polyurethanes, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, carpets, engineering plastics and artificial leather products.
Industry, Sector and Symbol:
- Sector: Basic Materials
- Industry: Specialty Chemicals
- Sub-Industry: N/A
- Symbol: NYSE:BIOA
- CUSIP: N/A
- Web: www.bio-amber.com
Capitalization:- Market Cap: $19.91 million
- Outstanding Shares: 37,102,000
Average Prices:- 50 Day Moving Avg: $0.65
- 200 Day Moving Avg: $1.96
- 52 Week Range: $0.32 - $6.50
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -10.73
- P/E Growth: 0.0000
Sales & Book Value:- Annual Revenue: $10.54 million
- Price / Sales: 1.89
- Book Value: $1.86 per share
- Price / Book: 0.29
Profitability:- EBIDTA: ($24,980,000.00)
- Net Margins: -221.82%
- Return on Equity: -56.55%
- Return on Assets: -21.56%
Debt:- Debt-to-Equity Ratio: 0.45%
- Current Ratio: 1.50%
- Quick Ratio: 1.03%
Misc:- Average Volume: 1.09 million shs.
- Beta: 2.7
Frequently Asked Questions for BioAmber (NYSE:BIOA)
What is BioAmber's stock symbol?
BioAmber trades on the New York Stock Exchange (NYSE) under the ticker symbol "BIOA."
How were BioAmber's earnings last quarter?
BioAmber Inc. (NYSE:BIOA) announced its quarterly earnings data on Thursday, August, 3rd. The company reported ($0.20) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.17) by $0.03. The business had revenue of $4.12 million for the quarter, compared to analyst estimates of $4.09 million. BioAmber had a negative return on equity of 56.55% and a negative net margin of 221.82%. View BioAmber's Earnings History.
When will BioAmber make its next earnings announcement?
Where is BioAmber's stock going? Where will BioAmber's stock price be in 2017?
1 equities research analysts have issued 1-year price targets for BioAmber's shares. Their forecasts range from $3.00 to $3.00. On average, they anticipate BioAmber's stock price to reach $3.00 in the next year. View Analyst Ratings for BioAmber.
Who are some of BioAmber's key competitors?
Some companies that are related to BioAmber include Banro (BAA), Plant Health Care plc (PHC), Anglo Asian Mining Plc (AAZ), Comstock Mining (LODE), Cequence Energy Ltd (CQE), Foraco International S.A. (FAR), Thompson Creek Metals Company (TC), Magnum Hunter Resources Corp (MHR), Marrone Bio Innovations (MBII), Sylvania Platinum Ltd (SLP), Clean Diesel Technologies (CDTI), Paramount Gold Nevada Corp. (PZG), Paramount Gold Nevada Corp (PZG), Verde Agritech PLC (NPK), Eastern Platinum (ELR), Serabi Gold PLC (SRB), Shanta Gold Limited (SHG) and Hardide Plc (HDD).
Who are BioAmber's key executives?
BioAmber's management team includes the folowing people:
- Raymond J. Land, Chairman of the Board
- Fabrice Orecchioni, President, Chief Operating Officer
- Mario Settino, Chief Financial Officer
- Michael A. Hartmann, Executive Vice President
- James Millis, Chief Technology Officer
- Robert Frost, Director
- Kurt W. Briner, Independent Director
- Heinz Haller, Independent Director
- Ellen B. Richstone, Independent Director
- Kenneth W Wall, Independent Director
Who owns BioAmber stock?
BioAmber's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include NN Investment Partners Holdings N.V. (7.73%), FMR LLC (3.67%), Robecosam AG (2.18%), Royce & Associates LP (2.09%), Baillie Gifford & Co. (1.56%) and TD Asset Management Inc. (1.03%). Company insiders that own BioAmber stock include George Frederick John Gosbee, Jean-Francois Huc, Kenneth W Wall, Kurt W Briner, Mario Settino and Michael A Hartmann. View Institutional Ownership Trends for BioAmber.
Who sold BioAmber stock? Who is selling BioAmber stock?
Who bought BioAmber stock? Who is buying BioAmber stock?
BioAmber's stock was bought by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., TD Asset Management Inc., Bank of New York Mellon Corp, Vanguard Group Inc. and FMR LLC. Company insiders that have bought BioAmber stock in the last two years include George Frederick John Gosbee, Jean-Francois Huc, Kenneth W Wall, Kurt W Briner, Mario Settino and Michael A Hartmann. View Insider Buying and Selling for BioAmber.
How do I buy BioAmber stock?
Shares of BioAmber can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is BioAmber's stock price today?
One share of BioAmber stock can currently be purchased for approximately $0.54.
MarketBeat Community Rating for BioAmber (NYSE BIOA)MarketBeat's community ratings are surveys of what our community members think about BioAmber and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Earnings History for BioAmber (NYSE:BIOA)Earnings History by Quarter for BioAmber (NYSE BIOA)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 11/1/2017 | | ($0.16) | | | | | N/A |  |
| 8/3/2017 | 6/30/2017 | ($0.17) | ($0.20) | $4.09 million | $4.12 million | View | Listen | |
| 5/9/2017 | 3/31/2017 | ($0.13) | ($0.31) | $3.65 million | $2.12 million | View | Listen | |
| 3/16/2017 | 12/31/2016 | ($0.19) | ($0.31) | $3.77 million | $0.63 million | View | N/A | |
| 11/3/2016 | Q216 | ($0.22) | ($0.26) | $3.75 million | $3.66 million | View | N/A | |
| 8/9/2016 | Q116 | ($0.27) | ($0.25) | $2.37 million | $2.50 million | View | N/A | |
| 3/14/2016 | Q415 | ($0.35) | ($0.40) | $0.98 million | $1.11 million | View | N/A | |
| 11/4/2015 | Q315 | ($0.41) | ($0.27) | $2.30 million | $0.35 million | View | N/A | |
| 3/12/2015 | Q414 | ($0.39) | ($0.48) | | ($0.31) million | View | N/A | |
| 11/6/2014 | Q3 2014 | ($0.40) | ($0.41) | | $0.47 million | View | N/A | |
| 8/7/2014 | Q2 2014 | ($0.40) | $0.40 | $0.45 million | $0.42 million | View | N/A | |
| 3/13/2014 | | ($0.36) | ($0.45) | | | View | Listen | |
(Data available from 1/1/2011 forward)
Earnings Estimates for BioAmber (NYSE:BIOA)Current Year EPS Consensus Estimate: $-0.5800 EPS
Next Year EPS Consensus Estimate: $-0.0500 EPS
Dividend History for BioAmber (NYSE:BIOA)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for BioAmber (NYSE:BIOA)Insider Ownership Percentage: 8.33%
Institutional Ownership Percentage: 37.40%
Insider Trades by Quarter for BioAmber (NYSE:BIOA)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 8/18/2017 | Michael A Hartmann | Insider | Buy | 10,000 | $0.48 | $4,800.00 | |
| 8/9/2017 | Mario Settino | CFO | Buy | 15,000 | $0.53 | $7,950.00 | |
| 11/9/2016 | George Frederick John Gosbee | Director | Buy | 25,000 | $3.87 | $96,750.00 | |
| 11/8/2016 | Kurt W Briner | Director | Buy | 10,000 | $3.84 | $38,400.00 | |
| 5/24/2016 | Kurt W Briner | Director | Buy | 1,000 | $3.69 | $3,690.00 | |
| 5/23/2016 | Kurt W Briner | Director | Buy | 21,015 | $3.61 | $75,864.15 | |
| 5/11/2016 | Jean-Francois Huc | CEO | Buy | 10,000 | $3.22 | $32,200.00 | |
| 5/9/2016 | Kenneth W Wall | Director | Buy | 13,227 | $3.11 | $41,135.97 | |
| 5/6/2016 | Michael A Hartmann | EVP | Buy | 3,000 | $3.44 | $10,320.00 | |
| 12/3/2015 | Jean-Francois Huc | CEO | Sell | 27,278 | $8.11 | $221,224.58 | |
| 12/3/2015 | Michael A. Hartmann | EVP | Sell | 21,477 | $8.11 | $174,178.47 | |
| 8/14/2015 | Michael A Hartmann | EVP | Buy | 1,500 | $6.75 | $10,125.00 | |
| 8/11/2015 | Jean-Francois Huc | CEO | Buy | 4,000 | $6.18 | $24,720.00 | |
| 8/10/2015 | Raymond J Land | Director | Buy | 1,500 | $6.71 | $10,065.00 | |
| 5/6/2015 | Jean-Francois Huc | CEO | Buy | 8,800 | $9.00 | $79,200.00 | |
| 5/6/2015 | Kurt W Briner | Director | Buy | 10,000 | $9.00 | $90,000.00 | |
| 5/6/2015 | Michael A Hartmann | EVP | Buy | 1,100 | $9.00 | $9,900.00 | |
| 12/11/2014 | Kenneth W Wall | Director | Buy | 3,000 | $9.20 | $27,600.00 | |
| 12/10/2014 | Kenneth W Wall | Director | Buy | 5,000 | $9.30 | $46,500.00 | |
| 11/10/2014 | Kurt W Briner | Director | Buy | 15,000 | $9.35 | $140,250.00 | |
| 9/9/2014 | Kurt W Briner | Director | Buy | 5,000 | $12.00 | $60,000.00 | |
| 8/25/2014 | Kurt W Briner | Director | Buy | 14,250 | $11.50 | $163,875.00 | |
| 8/11/2014 | Kurt W Briner | Director | Buy | 2,980 | $11.45 | $34,121.00 | |
| 7/16/2014 | Jean-Francois Huc | CEO | Buy | 4,000 | $12.00 | $48,000.00 | |
| 7/16/2014 | Michael A Hartmann | EVP | Buy | 3,000 | $12.00 | $36,000.00 | |
| 5/12/2014 | Andrew P Ashworth | CFO | Buy | 3,000 | $10.00 | $30,000.00 | |
| 5/12/2014 | Michael A Hartmann | EVP | Buy | 2,500 | $10.05 | $25,125.00 | |
| 11/14/2013 | Kurt W Briner | Director | Buy | 7,200 | $6.95 | $50,040.00 | |
| 9/3/2013 | Michael A Hartmann | EVP | Buy | 2,000 | $4.63 | $9,260.00 | |
| 8/29/2013 | Jean-Francois Huc | CEO | Buy | 5,000 | $4.25 | $21,250.00 | |
| 8/15/2013 | Kurt W Briner | Director | Buy | 13,000 | $5.49 | $71,370.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for BioAmber (NYSE:BIOA)
Latest Headlines for BioAmber (NYSE:BIOA)
| Source: |
|
| Date | Headline |
|---|
 | Reviewing Innospec (IOSP) & BioAmber (BIOA)
www.americanbankingnews.com - September 19 at 12:48 AM |
 | Form 8-K BioAmber Inc. For: Sep 11 - StreetInsider.com
www.streetinsider.com - September 16 at 4:15 PM |
 | BioAmber Announces New Chief Executive Officer
finance.yahoo.com - September 14 at 5:14 PM |
| Analyzing BioAmber (BIOA) and Its Rivals
www.americanbankingnews.com - September 13 at 6:22 PM |
| BioAmber Inc. Receives Notice of Non-Compliance from the NYSE
finance.yahoo.com - September 13 at 5:42 PM |
 | BRIEF-Sabby Management LLC reports 6.15 pct passive stake in BioAmber inc - SEC filing
www.reuters.com - September 13 at 3:07 AM |
| Form SC 13G BioAmber Inc. Filed by: SABBY MANAGEMENT, LLC - StreetInsider.com
www.streetinsider.com - September 12 at 4:50 PM |
| BRIEF-NN Group N.V. reports 15.91 pct passive stake in Bioamber
www.reuters.com - September 8 at 10:00 PM |
| Kronos Worldwide (KRO) versus BioAmber (BIOA) Head-To-Head Review
www.americanbankingnews.com - September 2 at 2:26 AM |
| BioAmber, Inc. :BIOA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
finance.yahoo.com - August 25 at 6:18 PM |
| Head to Head Review: Ferro Corporation (FOE) versus BioAmber (BIOA)
www.americanbankingnews.com - August 14 at 12:52 PM |
| BioAmber Inc. (BIOA) Stock Rating Lowered by ValuEngine
www.americanbankingnews.com - August 8 at 11:28 PM |
| BioAmber (BIOA) Prices $11M Offering of Common Stock, Warrants
www.streetinsider.com - August 8 at 9:23 PM |
| BRIEF-Bioamber prices public offering of 14.7 mln shares at $0.75/shr
www.reuters.com - August 8 at 9:23 PM |
 | Mid-Afternoon Market Update: Michael Kors Gains On Earnings Beat; Commercial Vehicle Shares Slide - Nasdaq
www.nasdaq.com - August 8 at 4:20 PM |
| Mid-Day Market Update: Stocks Turn Higher; Depomed Shares Plummet - Nasdaq
www.nasdaq.com - August 8 at 4:20 PM |
 | BioAmber Inc. Announces US$11 Million Underwritten Offering of Common Stock and Warrants - MarketWatch
www.marketwatch.com - August 8 at 4:20 PM |
| BioAmber Inc. Announces US$11 Million Underwritten Offering of Common Stock and Warrants
finance.yahoo.com - August 8 at 4:20 PM |
| BioAmber Inc. Announces Underwritten Offering of Common Stock and Warrants - MarketWatch
www.marketwatch.com - August 8 at 3:05 AM |
| BioAmber (BIOA) Announces Underwritten Common Offering
www.streetinsider.com - August 7 at 10:05 PM |
| BRIEF-BioAmber announces underwritten offering of common stock and warrants
www.reuters.com - August 7 at 5:04 PM |
| BioAmber Inc. Announces Underwritten Offering of Common Stock and Warrants
finance.yahoo.com - August 7 at 5:04 PM |
 | BioAmber's (BIOA) Management on Q2 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - August 6 at 4:02 PM |
 | BioAmber announces record revenues for the second quarter 2017 and purchase of Mitsui equity stake in Sarnia Joint ... - PR Newswire (press release)
www.prnewswire.com - August 4 at 9:50 PM |
| BioAmber Inc. (BIOA) Issues Earnings Results
www.americanbankingnews.com - August 4 at 8:58 PM |
| Edited Transcript of BIOA earnings conference call or presentation 3-Aug-17 12:30pm GMT
finance.yahoo.com - August 3 at 11:02 PM |
| Investor Network: BioAmber, Inc. to Host Earnings Call
finance.yahoo.com - August 3 at 6:01 PM |
| BioAmber announces record revenues for the second quarter 2017 and purchase of Mitsui equity stake in Sarnia Joint Venture
finance.yahoo.com - August 3 at 6:01 PM |
| BioAmber reports 2Q loss
finance.yahoo.com - August 3 at 6:01 PM |
| BioAmber Announces Webcast of Fiscal Second Quarter 2017 Financial Results
finance.yahoo.com - August 1 at 5:25 PM |
| BioAmber Inc. (BIOA) Set to Announce Earnings on Monday
www.americanbankingnews.com - July 31 at 8:11 AM |
| Global Organic Acid Market By Type (Acetic Acid, Citric Acid, Formic Acid and Lactic Acid), By End Uses (Industrial ... - PR Newswire (press release)
www.prnewswire.com - July 27 at 10:03 PM |
| BioAmber Inc. (NYSE:BIOA) Upgraded to Hold by Zacks Investment Research
www.americanbankingnews.com - July 26 at 5:02 PM |
| Global Bio-Based Chemicals Market Forecast 2017-2025 - PR Newswire (press release)
www.prnewswire.com - July 20 at 11:11 PM |
 | Succinic Acid - Global Strategic Business Report 2017 - Rising Demand for Bio-Plastics: Opportunity for Bio-Succinic Acid Market
www.finanznachrichten.de - July 16 at 9:11 PM |
| BioAmber Inc. (BIOA) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - July 11 at 7:14 PM |
| Comparing BioAmber (NYSE:BIOA) and Kraton Corporation (KRA)
www.americanbankingnews.com - July 9 at 8:22 AM |
| BioAmber (NYSE:BIOA) & Rayonier Advanced Materials (RYAM) Head-To-Head Comparison
www.americanbankingnews.com - July 7 at 8:06 AM |
| BioAmber Inc. (BIOA) Lifted to Sell at ValuEngine
www.americanbankingnews.com - June 24 at 12:38 AM |
| BioAmber (BIOA) Announces Launch of BIO-SA Pharmaceutical Grade - StreetInsider.com
www.streetinsider.com - June 16 at 4:39 PM |
| BioAmber (BIOA) Announces Launch of BIO-SA Pharmaceutical Grade
www.streetinsider.com - June 15 at 5:43 PM |
| BioAmber Launches a Pharmaceutical Grade for its Bio-succinic Acid
finance.yahoo.com - June 15 at 5:43 PM |
| BioAmber Inc. (BIOA) Lowered to "Strong Sell" at ValuEngine
www.americanbankingnews.com - June 12 at 12:40 AM |
| TMX Group Equity Financing Statistics - May 2017
www.marketwatch.com - June 7 at 4:12 PM |
| Global Organic Acid Market, Competition Forecast and Opportunities, 2026 - Research and Markets
www.finanznachrichten.de - May 29 at 9:13 AM |
| BioAmber Announces Changes to its Board of Directors, the Appointment of a Chief Financial Officer and the Results ... - PR Newswire (press release)
www.prnewswire.com - May 17 at 8:59 PM |
 | Law Offices of Howard G. Smith Reminds BioAmber Inc. Investors of Pending Lawsuit and Upcoming Lead Plaintiff ... - Business Wire (press release)
www.businesswire.com - May 17 at 8:59 PM |
| Law Offices of Howard G. Smith Reminds BioAmber Inc. Investors of Pending Lawsuit and Upcoming Lead Plaintiff Deadline
finance.yahoo.com - May 16 at 4:00 PM |
| BIOA DEADLINE ALERT: The Law Offices of Vincent Wong Notifies Investors of BioAmber Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 17, 2017 - BIOA
finance.yahoo.com - May 16 at 4:00 PM |
| BIOA ALERT: Rosen Law Firm Reminds BioAmber Inc. Investors of Important May 17 Deadline in First Filed Class Action - BIOA
finance.yahoo.com - May 16 at 12:37 PM |
BioAmber (BIOA) Chart for Wednesday, September, 20, 2017
